 |
인쇄하기
취소
|
Kwangdong faces damage suit
Mypharm said on May 21 it would seek 10.0 billion won in compensation from Kwangdong Pharm for sales losses caused by the Kwangdong’s illegal use of a trademark “Humassen” owned by Mypharm.
Humassen is a human placenta that has been under developed by Mypharm.
“We will take legal action against Kwangdong, including filing compensation suits for sales loss,’’ an official of Mypharm said. ...
Humassen is a human placenta that has been under developed by Mypharm.
“We will take legal action against Kwangdong, including filing compensation suits for sales loss,’’ an official of Mypharm said. ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.